[Etiopathogenetic differentiation of inflammatory cardiomyopathy. Immunosuppression and immunomodulation]

Internist (Berl). 1997 Jun;38(6):590-601. doi: 10.1007/s001080050071.

[Article in German]

Authors

U Kühl¹, M Pauschinger, H P Schultheiss

Affiliation

¹ Med. Klinik II Kardiologie und Pulmonologie, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin.

PMID: 9265004
DOI: 10.1007/s001080050071

No abstract available

Publication types

Review

MeSH terms

Adjuvants, Immunologic / adverse effects
Adjuvants, Immunologic / therapeutic use*
Autoimmune Diseases / drug therapy*
Autoimmune Diseases / immunology
Autoimmune Diseases / pathology
Cardiomyopathy, Dilated / drug therapy
Cardiomyopathy, Dilated / immunology
Cardiomyopathy, Dilated / pathology
Chronic Disease
Diagnosis, Differential
Humans
Immunosuppressive Agents / adverse effects
Immunosuppressive Agents / therapeutic use*
Myocarditis / drug therapy*
Myocarditis / immunology
Myocarditis / pathology
Myocardium / immunology
Myocardium / pathology

Substances

Adjuvants, Immunologic
Immunosuppressive Agents